ALGN Align Technology

Q3 2025 10-Q

Filed: Nov 5, 2025Period ending Sep 30, 2025

Health Care

Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR

Align Technology (ALGN) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $996M, up 1.8% YoY; Clear Aligner $806M, up 2.4%, Systems and Services $190M, down 0.6% YoY
• Operating margin 9.7% vs 16.6% YoY; Clear Aligner margin 31.1% vs 35.1%, Systems and Services margin 31.5% vs 36.0% YoY

+3 more insights

Risk Factors

• New geopolitical risk: Ongoing Israel-Hamas conflict near iTero operations since October 7, 2023, with uncertain ceasefire sustainability impacting personnel and facilities
• Most material regulatory risk: Post-June 2024 U.S. Supreme Court Chevron reversal increases challenges to FDA authority, risking delays in regulatory approvals

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$996M

▲ +1.8% YoY▼ -1.7% QoQ

Net Income

$57M

▼ -51.1% YoY▼ -54.5% QoQ

Net Margin

5.7%

▼ -616bp YoY▼ -661bp QoQ

Source: XBRL data from Align Technology Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Align Technology

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.